Otto Chemie Pvt. Ltd.

Phone : +91-22-2207 0099
Email : info@ottokemi.com, sales@ottokemi.com


Product Details

PSMA 617

2-[3-(1-Carboxy-5-{3-naphthalen-2-yl-2-[(4-{[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetylamino]-methyl}-cyclohexanecarbonyl)-amino]-propionylamino}-pentyl)-ureido]-pentanedioic acid, PSMA617 TFA; PSMA617 triflouroacetic acid salt; vipivotide tetraxetan; DKFZ-PSMa-617

PS 0090

puriss

C49H71N9O16.CF3COOH

29420090

18%

1702967-37-0

95%+

1042.14 (net)

Vial / Bottle

PS 0090 (OTTO) PSMA 617 Cas 1702967-37-0 - used in chemical research.

PSMA-617 - a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer.

Properties

Cell biology, Cancer research

95%+

Powder

Colourless to white to off-white

1041.5

-20 °C


Safety Information

Safety Information for this product is unavailable at this time.


PSMA-617
PackingsPrice (INR)
1 mg 488363.00
5 mg POR
1 gm POR

DisclaimerThe above particulars do not release the customer from the obligation to carry out an inspection of goods received.
For laboratory use only. Not for drug, medical, household, or any other unauthorized application.
We assume no liability for misuse or unauthorized application of the product. Please test before use.